Fig. 2From: Overall survival in patients with advanced non-small cell lung cancer with KRAS G12C mutation with or without STK11 and/or KEAP1 mutations in a real-world settingPrevalence of Metastasis in Patients With aNSCLC Treated in the 1L. 1L, first line; aNSCLC, advanced non-small cell lung cancer; WT, wild typeBack to article page